Efficacy and safety of interferon on neonates with respiratory syncytial virus pneumonia

Respiratory syncytial virus (RSV) pneumonia is a leading cause of hospitalization and mortality among neonates worldwide, and there are currently no specific clinical treatments for RSV infection. Interferons (IFNs) possess broad-spectrum antiviral properties, and the present study aimed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lingyun, Yang, Lu, Zhang, Hua, Luo, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646691/
https://www.ncbi.nlm.nih.gov/pubmed/33193835
http://dx.doi.org/10.3892/etm.2020.9350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646691/
https://www.ncbi.nlm.nih.gov/pubmed/33193835
http://dx.doi.org/10.3892/etm.2020.9350

Ejemplares similares